We are live on ! Find out more
VTYX

Ventyx Biosciences
VTYX

Delisted

VTYX was delisted on the 3rd of March, 2026.

Back to rankings

117 hedge funds and large institutions have $132M invested in Ventyx Biosciences in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 37 increasing their positions, 37 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 37

7% less funds holding

Funds holding: 126 → 117 (-9)

18.37% less ownership

Funds ownership: 99.58% → 81.21% (-18%)

25% less call options, than puts

Call options by funds: $670K | Put options by funds: $896K

28% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 29

59% less capital invested

Capital invested by funds: $324M → $132M (-$192M)

Holders
117
Holders Change
-9
Holders Change %
-7.14%
% of All Funds
1.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
21
Increased
37
Reduced
37
Closed
29
Calls
$670K
Puts
$896K
Net Calls
-$226K
Net Calls Change
-$431K

Top Buyers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
+$12M
2
DM
Deerfield Management
New York
+$9.5M
3
VPC
Vestal Point Capital
New York
+$5.46M
4
BlackRock
BlackRock
New York
+$4.26M
5
OCA
Octagon Capital Advisors
New York
+$3.7M

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$14.9M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$13.9M
3
O
OrbiMed
New York
-$10.3M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$6.96M
5
SSA
Schonfeld Strategic Advisors
New York
-$5.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
JGC
126
J. Goldman & Co
New York
– -$342K -62,262 Closed
NYLIM
127
New York Life Investment Management
New York
– -$335K -60,850 Closed
ECM
128
ExodusPoint Capital Management
New York
– -$247K -44,911 Closed
XT
129
XTX Topco
Cayman Islands
– -$207K -37,547 Closed
FRM
130
Fox Run Management
Connecticut
– -$184K -33,490 Closed
AIG
131
American International Group
New York
– -$127K -23,064 Closed
Ameriprise
132
Ameriprise
Minnesota
– -$122K -22,253 Closed
Franklin Resources
133
Franklin Resources
California
– -$96.5K -17,553 Closed
ZIM
134
Zacks Investment Management
Illinois
– -$89.7K -16,304 Closed
Principal Financial Group
135
Principal Financial Group
Iowa
– -$72.5K -13,180 Closed
FIA
136
FNY Investment Advisers
New York
– -$71 -13,000 Closed
Balyasny Asset Management
137
Balyasny Asset Management
Illinois
– -$63.1K -11,480 Closed
Vontobel Holding
138
Vontobel Holding
Switzerland
– -$55K -10,000 Closed
QT
139
Quantbot Technologies
New York
– -$28.5K -5,177 Closed
BBHC
140
Brown Brothers Harriman & Co
New York
– -$15.6K -2,845 Closed
MLICM
141
Metropolitan Life Insurance Company (MetLife)
New York
– -$14.2K -2,579 Closed
AW
142
Avion Wealth
Texas
– -$1K -63 Closed
Zurich Cantonal Bank
143
Zurich Cantonal Bank
Switzerland
– -$303 -55 Closed
AWM
144
Avior Wealth Management
Nebraska
– -$49 -9 Closed
CAL
145
Capital Advisors Ltd
Ohio
– +$62 +15 New
2 3 4 5
6

VTYX Hedge Fund Activity: Q2 2024 in Review

117 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q2 2024, worth a combined $132M — down 59% from $324M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of VTYX and 21 opened new positions — a net loss of 8 holders — while 37 trimmed existing stakes and 37 added.

The largest buyer was Capital International Investors, adding an estimated $12M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $14.9M sold.

  • 117 institutional investors held Ventyx Biosciences (VTYX) as of Q2 2024, down from 126 in Q1 2024.
  • Funds reported $132M of Ventyx Biosciences stock for Q2 2024, down 59% quarter-over-quarter.
  • 21 funds opened new Ventyx Biosciences positions in Q2 2024 and 29 closed out, a net change of -8 holders.
  • The largest Ventyx Biosciences buyer in Q2 2024 was Capital International Investors, an estimated $12M added.
  • The largest Ventyx Biosciences seller in Q2 2024 was Cormorant Asset Management, an estimated $14.9M sold.

Based on aggregated 13F filings for Q2 2024.